This is not the most recent version of the article. View current version (22 JAN 2015)

Intervention Protocol

You have free access to this content

Dehydroepiandrosterone for menopausal women

  1. Carola S Scheffers1,*,
  2. Sarah Armstrong2,
  3. Astrid EP Cantineau3,4,
  4. Cindy Farquhar2

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 14 APR 2014

DOI: 10.1002/14651858.CD011066


How to Cite

Scheffers CS, Armstrong S, Cantineau AEP, Farquhar C. Dehydroepiandrosterone for menopausal women (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD011066. DOI: 10.1002/14651858.CD011066.

Author Information

  1. 1

    University of Groningen, Groningen, Netherlands

  2. 2

    University of Auckland, Department of Obstetrics and Gynaecology, Auckland, New Zealand

  3. 3

    University Medical Centre, Department of Obstetrics and Gynaecology, Groningen, Netherlands

  4. 4

    University of Groningen, Department of Obstetrics and Gynaecology, Groningen, Netherlands

*Carola S Scheffers, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV, Netherlands. c.s.scheffers@student.rug.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 14 APR 2014

SEARCH

This is not the most recent version of the article. View current version (22 JAN 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effectiveness and safety of administering DHEA to women with menopausal symptoms.